These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11738349)

  • 1. In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG.
    Murugasu-Oei B; Dick T
    Int J Antimicrob Agents; 2001 Dec; 18(6):579-82. PubMed ID: 11738349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial and antifungal activities of nitroxoline Mannich bases.
    Medić-Sarić M; Maysinger D; Movrin M; Dvorzak I
    Chemotherapy; 1980; 26(4):263-7. PubMed ID: 6771105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli.
    Khan A; Sarkar D
    J Microbiol Methods; 2008 Apr; 73(1):62-8. PubMed ID: 18328582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp.
    Arai M; Kamiya K; Pruksakorn P; Sumii Y; Kotoku N; Joubert JP; Moodley P; Han C; Shin D; Kobayashi M
    Bioorg Med Chem; 2015 Jul; 23(13):3534-41. PubMed ID: 25934225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation of the chelating property of nitroxoline, the surface hydrophobicity and the inhibition of bacterial adherence].
    Bourlioux P; Karam D; Amgar A; Perdiz M
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):600-4. PubMed ID: 2571967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria.
    Pruksakorn P; Arai M; Kotoku N; Vilchèze C; Baughn AD; Moodley P; Jacobs WR; Kobayashi M
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3658-63. PubMed ID: 20483615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria.
    McGaw LJ; Lall N; Hlokwe TM; Michel AL; Meyer JJ; Eloff JN
    Biol Pharm Bull; 2008 Jul; 31(7):1429-33. PubMed ID: 18591787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc.
    Sobke A; Klinger M; Hermann B; Sachse S; Nietzsche S; Makarewicz O; Keller PM; Pfister W; Straube E
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6021-5. PubMed ID: 22926564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
    Ritz N; Tebruegge M; Connell TG; Sievers A; Robins-Browne R; Curtis N
    Antimicrob Agents Chemother; 2009 Jan; 53(1):316-8. PubMed ID: 18955515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro drug susceptibility of Mycobacterium bovis BCG Connaught and Tokyo strains.
    Shimizu T; Yasumoto K; Tatano Y; Tomioka H; Sato K; Sano C; Kumon H; Monden K
    J Infect; 2010 Mar; 60(3):248-51. PubMed ID: 20074586
    [No Abstract]   [Full Text] [Related]  

  • 13. Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.
    Murugasu-Oei B; Dick T
    J Antimicrob Chemother; 2000 Dec; 46(6):917-9. PubMed ID: 11102410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 17. Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent.
    Arai M; Sobou M; Vilchéze C; Baughn A; Hashizume H; Pruksakorn P; Ishida S; Matsumoto M; Jacobs WR; Kobayashi M
    Bioorg Med Chem; 2008 Jul; 16(14):6732-6. PubMed ID: 18556206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.
    Djemal SE; Camperio C; Armas F; Siala M; Smaoui S; Messadi-Akrout F; Gdoura R; Marianelli C
    BMC Vet Res; 2018 Sep; 14(1):296. PubMed ID: 30268120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates.
    Kolibab K; Derrick SC; Morris SL
    J Clin Microbiol; 2011 Jun; 49(6):2380-1. PubMed ID: 21508153
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro antifungal activity of nitroxoline. Preliminary clinical results].
    Cancet B; Amgar A
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):879-81. PubMed ID: 3309833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.